Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl sulfoxide versus topical tretinoin for primary localized cutaneous amyloidosis
IRCT20181114041658N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in primary cutaneous amyloidosis (PCA) comparing Topical dimethyl sulfoxide side with Topical tretinoin side (2 arms). Primary endpoints: melanin, erythema and 1 more. Started Mar 2019; status: completed.
02
Drugs
Dimethyl sulfoxidetretinoin
03
Conditions
primary cutaneous amyloidosis (PCA)
Beyond the preview
Go deeper on IRCT20181114041658N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181114041658N1.